Immunosuppressant Drug Monitoring Market: By Product (Equipment, Consumables) By Technology (Proteomics Technologies, Immunoassays, Electrophoresis, Spectrometry) By Drugs (Antibodies, Corticosteroids, Calcineurin Inhibitors, Anti-Proliferative Agents, mTOR Inhibitors, Others) By Disease (Autoimmune Disorders, Organ Transplantation, Non-Auto Immune Inflammatory Diseases) By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Academic Institutes) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Immunosuppressant Drug Monitoring Market size was valued at USD x million in 2023 and is poised to grow at a CAGR of x% from 2024 - 2030. Immunosuppressant drug monitoring is most vital for monitoring of immunosuppressant drug levels in patients in order to prevent organ rejection. It is one of the applications of therapeutic drug monitoring, aims to maintain the adequate concentration of drugs in body fluids in order to refine patient care by adjusting individual drug dosage for better outcomes. Immunosuppressant drugs are known as anti-rejection drugs, which inhibit the activity of the immune system that are most commonly used in organ transplantations, autoimmune disorders like multiple sclerosis, rheumatoid arthritis, and chrons disease. Growing demand for organ transplantations, advancements in procedures of organ transplantation, and growing prevalence of autoimmune diseases are expected to witness tremendous growth of the immunosuppressant drug monitoring market. Furthermore, favorable reimbursement policies and growing awareness among the people regarding healthcare and organ transplantations are expected to fuel the immunosuppressant drug monitoring market.

However, strict regulatory frameworks and the availability of alternative therapies like stem cell therapy for immunosuppression are expected to hamper the growth of the immunosuppressant drug monitoring market. Therapeutic drug monitoring is a method of determining the drug's safe and effective dosage. Therapeutic Drug Monitoring is a technique for treating and monitoring drug concentrations in body fluids, most often plasma. A major element driving the global market's growth is the growing demand for better healthcare facilities in developing countries to meet the needs of a growing urban population. Furthermore, the growing elderly population and the development of novel medication management systems, particularly in emerging nations, are two major drivers driving market expansion.

Immunosuppressant Drug Monitoring Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

X%

Largest Market

North America

Fastest Growing Market

North America
Immunosuppressant Drug Monitoring Market Dynamics

Immunosuppressant drug monitoring market is growing at a significant rate due to rise in prevalence of autoimmune disorders and organ transplantations. As per WHO statistics, about 119,873 organ transplantation cases were reported in 2014, raised about 1.8% from 2013. Growing prevalence of autoimmune disorders and rise in investments in R&D activities for innovation of new procedures are expected to propel the immunosuppressant drug monitoring market over the forecast timeframe. Moreover, acquisitions and mergers, new product approvals, and product launches are major strategies followed by market players for increasing the revenue in immunosuppressant drug monitoring market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Immunosuppressant Drug Monitoring Market Segmentation

By Product Type
  • Equipment,
  • Consumables
By Technology
  • Proteomics Technologies,
  • Immunoassays,
  • Electrophoresis,
  • Spectrometry
By Drug Type
  • Antibodies,
  • Corticosteroids,
  • Calcineurin Inhibitors,
  • Anti-Proliferative Agents,
  • mTOR Inhibitors,
  • Others
By Disease
  • Autoimmune Disorders,
  • Organ Transplantation,
  • Non-Auto Immune Inflammatory Diseases
By End User
  • Hospitals,
  • Diagnostic Laboratories,
  • Research Institutes,
  • Academic Institutes

Frequently Asked Questions

The immunosuppressant drug monitoring market size was valued at USD x million in 2023

The immunosuppressant drug monitoring market key players are: Thermo Fisher Scientific Hoffmann-La Roche AG Bio-Rad Laboratories Inc. Abbott Laboratories Siemens Healthcare Danaher Corporation

The immunosuppressant drug monitoring market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1.Executive Summary
2.Global Immunosuppressant Drug Monitoring Market Introduction 
2.1.Global Immunosuppressant Drug Monitoring Market  - Taxonomy
2.2.Global Immunosuppressant Drug Monitoring Market  - Definitions
2.2.1. Product Type
2.2.2. Technology
2.2.3. Drug Type
2.2.4. Disease
2.2.5. End User
3.Global Immunosuppressant Drug Monitoring Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Immunosuppressant Drug Monitoring Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Immunosuppressant Drug Monitoring Market  By By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Equipment,
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Consumables
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Immunosuppressant Drug Monitoring Market  By By Technology, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Proteomics Technologies,
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Immunoassays,
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Electrophoresis,
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Spectrometry
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Immunosuppressant Drug Monitoring Market  By By Drug Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Antibodies,
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Corticosteroids,
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Calcineurin Inhibitors,
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Anti-Proliferative Agents,
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. mTOR Inhibitors,
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Others
7.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
8.Global Immunosuppressant Drug Monitoring Market  By By Disease, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. Autoimmune Disorders,
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Organ Transplantation,
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Non-Auto Immune Inflammatory Diseases
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Immunosuppressant Drug Monitoring Market  By By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Hospitals,
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Diagnostic Laboratories,
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Research Institutes,
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Academic Institutes
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
10.Hospitals, Immunosuppressant Drug Monitoring Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. By Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Equipment,
10.1.2.Consumables
10.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Proteomics Technologies,
10.2.2.Immunoassays,
10.2.3.Electrophoresis,
10.2.4.Spectrometry
10.3.  By Drug Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Antibodies,
10.3.2.Corticosteroids,
10.3.3.Calcineurin Inhibitors,
10.3.4.Anti-Proliferative Agents,
10.3.5.mTOR Inhibitors,
10.3.6.Others
10.4.  By Disease Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Autoimmune Disorders,
10.4.2.Organ Transplantation,
10.4.3.Non-Auto Immune Inflammatory Diseases
10.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Diagnostic Laboratories, Immunosuppressant Drug Monitoring Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Equipment,
11.1.2.Consumables
11.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Proteomics Technologies,
11.2.2.Immunoassays,
11.2.3.Electrophoresis,
11.2.4.Spectrometry
11.3.  By Drug Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Antibodies,
11.3.2.Corticosteroids,
11.3.3.Calcineurin Inhibitors,
11.3.4.Anti-Proliferative Agents,
11.3.5.mTOR Inhibitors,
11.3.6.Others
11.4.  By Disease Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Autoimmune Disorders,
11.4.2.Organ Transplantation,
11.4.3.Non-Auto Immune Inflammatory Diseases
11.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
11.5.7.
12.Research Institutes, Immunosuppressant Drug Monitoring Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Equipment,
12.1.2.Consumables
12.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Proteomics Technologies,
12.2.2.Immunoassays,
12.2.3.Electrophoresis,
12.2.4.Spectrometry
12.3.  By Drug Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Antibodies,
12.3.2.Corticosteroids,
12.3.3.Calcineurin Inhibitors,
12.3.4.Anti-Proliferative Agents,
12.3.5.mTOR Inhibitors,
12.3.6.Others
12.4.  By Disease Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Autoimmune Disorders,
12.4.2.Organ Transplantation,
12.4.3.Non-Auto Immune Inflammatory Diseases
12.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Academic Institutes Immunosuppressant Drug Monitoring Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
13.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Equipment,
13.1.2.Consumables
13.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Proteomics Technologies,
13.2.2.Immunoassays,
13.2.3.Electrophoresis,
13.2.4.Spectrometry
13.3.  By Drug Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Antibodies,
13.3.2.Corticosteroids,
13.3.3.Calcineurin Inhibitors,
13.3.4.Anti-Proliferative Agents,
13.3.5.mTOR Inhibitors,
13.3.6.Others
13.4.  By Disease Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Autoimmune Disorders,
13.4.2.Organ Transplantation,
13.4.3.Non-Auto Immune Inflammatory Diseases
13.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Proteomics Technologies,
14.2.2.Immunoassays,
14.2.3.Electrophoresis,
14.2.4.Spectrometry
14.3.  By Drug Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Antibodies,
14.3.2.Corticosteroids,
14.3.3.Calcineurin Inhibitors,
14.3.4.Anti-Proliferative Agents,
14.3.5.mTOR Inhibitors,
14.3.6.Others
14.4.  By Disease Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Autoimmune Disorders,
14.4.2.Organ Transplantation,
14.4.3.Non-Auto Immune Inflammatory Diseases
14.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Thermo Fisher Scientific
15.2.2.Hoffmann-La Roche AG
15.2.3.Bio-Rad Laboratories Inc.
15.2.4.Abbott Laboratories
15.2.5.Siemens Healthcare
15.2.6.Danaher Corporation
16. Research Methodology 
17. Appendix and Abbreviations 
  • Thermo Fisher Scientific
  • Hoffmann-La Roche AG
  • Bio-Rad Laboratories Inc.
  • Abbott Laboratories
  • Siemens Healthcare
  • Danaher Corporation

Adjacent Markets